Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Lite Strategy, Inc. (LITS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Lite Strategy, Inc. (LITS), most recent 12 months reported: net loss $71.15M. Latest balance sheet on file: liquid cash $5.71M. From SEC filings. Others in Pharmaceutical Preparations: KIORA PHARMACEUTICALS, INC. · PASITHEA THERAPEUTICS CORP. · Lakewood-Amedex Biotherapeutics Inc. · LB PHARMACEUTICALS INC · LARIMAR THERAPEUTICS, INC. · LANTERN PHARMA INC. · MAIA Biotechnology, Inc. · Veradermics, Inc

Stock screener

Watchlist